Navigation Links
Cholesterol-Lowering Drugs Safe for Long-Term Use, Study Finds
Date:11/23/2011

By Serena Gordon
HealthDay Reporter

TUESDAY, Nov. 22 (HealthDay News) -- British researchers have good news for anyone taking the cholesterol-lowering medications known as statins: These drugs are effective and safe, even when used for long periods of time, they say.

The 11-year study found that simvastatin (brand name Zocor) reduced the risk of cardiovascular disease by almost one-quarter. In addition, the researchers found no increase in illness or deaths from cancer or other non-vascular causes.

"All those at increased vascular risk should start taking statins early and continue taking them long term," said the study's lead author, Dr. Richard Bulbulia, a consultant vascular surgeon and research fellow in the clinical trial service unit at the University of Oxford in England.

"This will maximize the reductions in heart attacks, strokes and other vascular diseases, and is safe," said Bulbulia, who added that the study's findings should provide reassurance to physicians and their patients.

There are numerous other drugs in this class of medication, and Bulbulia said, "it seems reasonable to assume that [this study's findings] should hold true for other currently prescribed statins." Other commonly used statins include Lipitor, Crestor and Mevacor.

Results of the study are published in the Nov. 23 online issue of The Lancet. Funding for the study was provided by the U.K. Medical Research Council, the British Heart Foundation, Merck & Co. (manufacturer of Zocor) and Roche Vitamins.

The study looked at the long-term safety of simvastatin because some research suggested that the rates of some cancers and non-vascular health conditions were increased in people who had lower levels of LDL (bad) cholesterol.

Initially, the study recruited more than 20,500 people who had a high risk of heart disease and other cardiovascular problems for a trial of simvastatin versus a place
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Cholesterol-lowering drugs may help prevent recurrent strokes in younger people
2. Cholesterol-lowering drug shrinks enlarged prostates in hamster model
3. Chronic Bowel Disease Drugs Linked to Skin Cancer Risk
4. New class of drugs for the reversible inhibition of proteasomes
5. Testing antioxidant drugs is transparent
6. Old drugs find new target for treating brain tumor
7. Smart Kids More Likely to Try Illicit Drugs as Young Adults
8. Study helps eliminate causes for joint pain linked to commonly used breast cancer drugs
9. Drugs Slipped Into Drinks Sending Many to ER: Report
10. Scientists discover how to design drugs that could target particular nerve cells
11. More Than a Third of Teens Turning to Alcohol, Drugs: Study
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cholesterol-Lowering Drugs Safe for Long-Term Use, Study Finds
(Date:5/23/2015)... On May 13, Nithyananda Yoga Foundation organized a ... learned through meditation and initiation at Special Holistic School ... Yogamaatha, a nine-year-old girl from North Carolina, stunned an ... the 2015 Business Advocacy Summit at Capitol Hill in ... In a demonstration that lasted three hours, Yogamaatha was ...
(Date:5/23/2015)... CO (PRWEB) May 23, 2015 On May ... in MuckFest. The event was a 5k mud obstacle run ... more than 2 million people worldwide, and the reason we ... community,” said Chad Davis, owner of Farrell’s eXtreme Bodyshaping. “One-hundred ... Multiple Sclerosis Society.” , The event was not only attended ...
(Date:5/23/2015)... Add High-Quality prismatic refractions into footage using ProFlare ... simple as dragging and dropping footage into the FCPX timeline ... , Including over 80 stunning flares, ProFlare 5K Prism ... the ultimate bundle for adding prismatic refractions to any video. ... movie files designed for Final Cut Pro X, but are ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 The American ... exciting events in June. They will hold a webinar ... and a two-day class on Classical Chinese Medicine. , ... 3, Dr. Steve Given, the Dean of Clinical Education, ... the new First Professional Doctorate program. ACTCM is currently ...
(Date:5/22/2015)... Following yesterday’s announcement that Ascenta Health Limited has ... Nature’s Way, Marc St-Onge has affirmed his commitment to ... an integral part of the agreement with Nature’s Way ... develop Ascenta Skin into a leading player in the ... anti-aging skincare supplement featuring 6 active ingredients including therapeutic ...
Breaking Medicine News(10 mins):Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 2Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 3Health News:Farrell’s eXtreme Bodyshaping Team Runs through the Muck for MS 2Health News:Developers at Pixel Film Studios Release ProFlare 5K Prism for Final Cut Pro X. 2Health News:ACTCM Announces Upcoming June Events 2Health News:Ascenta Skin President Announces Plans to Grow Brand 2
... A Michigan State University surgeon is teaming up with ... create a simple, cost-effective saliva test to detect oral cancer, ... fewer people dying of the world,s sixth most common cancer. ... Medicine,s Department of Surgery and lead investigator on the project, ...
... TUESDAY, April 17 (HealthDay News) -- The ability to make ... changes in the brain,s white matter, a new imaging study ... 85, to perform a learning task involving money and also ... in decision-making are associated with the weakening of two specific ...
... Mothers with depression may behave in ways that disturb their ... University researchers conducted home visits with 45 mothers and their ... over 7 consecutive days to collect information about depression symptoms ... Greater amounts of sleep disruption were noted in infants whose ...
... TUESDAY, April 17 (HealthDay News) -- New research adds to ... (protein) plaques, the brain-clogging fragments that have been associated with ... Healthcare Berlin, researchers report that they were able to use ... the brains of patients whose Alzheimer,s was confirmed after death. ...
... HealthDay Reporter , TUESDAY, April 17 (HealthDay News) -- ... appear to get no survival benefit from adding the ... Cancer Institute report. An earlier trial had found ... patients aged 65 and older. Even so, the researchers ...
... drug bevacizumab (Avastin) to the standard chemotherapy regimen for non-small ... FDA in 2006 did not lead to significantly increase ... in Medicare, a new study by Dana-Farber Cancer Institute researchers ... April 18 Journal of the American Medical Association , ...
Cached Medicine News:Health News:Saliva test could dramatically increase detection of oral cancer 2Health News:Depressed Moms May Hinder Babies' Sleep 2Health News:New Method to Reveal Alzheimer's Marker Shows Promise 2Health News:Avastin No Benefit to Older Lung Cancer Patients: Study 2Health News:Avastin No Benefit to Older Lung Cancer Patients: Study 3Health News:Adding drug to standard chemotherapy provides no survival benefit for older lung cancer patients 2
(Date:5/22/2015)... R.I. , May 22, 2015 ... once-daily central nervous system stimulant indicated for the ... to patients beginning Summer 2015. ... XR received approval from the U.S. Food and ... is an extended-release formulation of methylphenidate capsule with ...
(Date:5/22/2015)... 2015 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX ... and commercialization of innovative therapies for the treatment of ... executive officer Howie Rosen will be presenting ... Tim Morris will be presenting at JMP ... are as follows: Jefferies 2015 Healthcare Conference ...
(Date:5/21/2015)... May 21, 2015  When Ryan Rendino ... side of his neck, he figured it ... couple weeks off from weight lifting. ...                               A series of ... referred to Michel Kliot, MD , ...
Breaking Medicine Technology:Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 2Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 3Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 4Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 5Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 6AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences In June 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 3Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 4
... Inc. (Nasdaq: NTY ) ( www.NBTY.com ), ... the United States, with operations globally, today announced it ... first quarter results on the Company website on Friday, ... are posted on the Company website at http://www.nbty.com/phoenix.zhtml?c=85635&p=irol-reportsannual ...
... Mass., March 14, 2011 Cellceutix Corporation (OTCQB: ... Company,s flagship compound for the potential treatment of ... has begun production for clinical trials. This was ... formulates developmental medications for clinical trials. ...
Cached Medicine Technology:NBTY to Webcast Fiscal First Quarter Conference Call 2Cellceutix Reports Production of Its Anti-Cancer Drug Kevetrin™ Has Begun 2Cellceutix Reports Production of Its Anti-Cancer Drug Kevetrin™ Has Begun 3
The ImagingPlanet 70 mm Surgical Microscope Adapter. Superior optical quality and precise engineering make this 70 mm focal length adapter an excellent decision for use with your Zeiss surgical micr...
The ImagingPlanet 70 mm surgical microscope video adapter: superior optical quality and precise engineering make this 70 mm focal length adapter an excellent decision for use with your Zeiss surgical...
The ImagingPlanet 80 mm surgical microscope video adapter: superior optical quality and precise engineering make this 80 mm focal length adapter an excellent decision for use with your Zeiss surgical...
The ImagingPlanet 55 mm surgical microscope video adapter: superior optical quality and precise engineering make this 55mm focal length adapter an excellent decision for use with your Leica surgical ...
Medicine Products: